L&T-TECHNOLOGY-SERVICES
9.3.2023 08:31:42 CET | Business Wire | Press release
L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global pure-play engineering services company, today announced a new Centre of Excellence (CoE) in Mysore (Karnataka, India) that leverages the power of the cloud with Amazon Web Services (AWS). The CoE will allow LTTS to transition its suite of cutting-edge technologies focused on the future of mobility and reduce time-to-market for end customers. By leveraging AWS infrastructure, LTTS will provide an opportunity to use AWS to support the automotive domain.
With its rich engineering domain expertise in Electric, Autonomous, and Connected Vehicles (EACV), LTTS has been helping OEMs to develop next-generation Vehicles and Aircraft that have tailored solutions focused on safety and security. The new CoE will leverage LTTS' cross-disciplinary skillsets covering embedded, mechanical, and digital facets of engineering.
LTTS has been actively working with global technology leaders like AWS to bring digital engineering solutions to end customers on the cloud. AnnotAI, Connected Cars, and SafeX are some of the LTTS solutions that will be deployed in AWS Marketplace to optimize R&D innovation on the cloud to create enterprise-leading technology solutions.
LTTS’ industry leading mobility solutions are helping OEMs to build innovative next-generation vehicles to meet and exceed the standards for transport safety, security, and emission regulations. LTTS’ AnnotAI, Connected Cars and SafeX solutions have already been deployed for leading global Automotive OEMs and Tier-1 customers, helping them reap significant faster time-to-market benefits. As part of the CoE, AWS software-defined vehicle and AWS IoT FleetWise will be used alongside LTTS’ digital offerings to collect and transfer the vehicle data to the cloud in near real time.
- AnnotAI: For the purpose of developing and testing a self-driving artificial intelligence (AI), a large amount of data is required, along with more engineering and data labeling services. LTTS’ intelligent data annotation platform AnnotAI provides smart labelling to media assets such as text, image, video, and LiDAR, thus empowering global vehicle manufacturers in their drive towards Level 5 autonomy (full driving automation or where the dynamic driving task is eliminated).
- Connected Car: LTTS’ Connected Car technologies offers automotive clients with state-of-the-art driver assistance systems, cloud services and connectivity modules which support in development of V2X platform definition, while implementing secured gateways and avoiding malicious attacks.
- SafeX: The automotive industry faces unique challenges when it comes to developing state-of-the-art software. SafeX DevOps and CI/CD automation allows automotive manufacturers to accelerate their releases while ensuring security and mitigating the risk of failed or recalled software releases.
LTTS’ suite of cutting-edge technologies has resulted in proven benefits for global customers.
A Spokesperson from BMW Group said, “The AnnotAI platform from LTTS, by enabling state-of-the-art image, video, and LiDAR data annotation capabilities on AWS, is driving a robust and integrated validation framework for BMW Group and helping the global leader in luxury vehicles engineer innovative and sustainable vehicles for the future.”
Amit Chadha, CEO and Managing Director, L&T Technology Services said, “Electric, Autonomous and Connected Vehicle (EACV) is the first of our six big bets that are helping global automotive players accelerate their technological development journey towards an autonomous and sustainable future built on the highest considerations of security and safety. By working with AWS, LTTS can help global automotive organizations realize the full potential of its high-performance and scalable technologies built on an agile AWS cloud infrastructure.”
Puneet Chandok, President of Commercial Business, AWS India & South Asia (Amazon Web Services India Pvt. Ltd.) said, “The digital transformation in the automotive industry is accelerating, in many cases thanks to innovative solutions coming from our AWS partners. LTTS’ digital engineering offerings will help our joint customers realize the benefits of moving to the cloud, such as reduced time to market, increased business value and accelerated pace of digital innovation. With the launch of the new Centre of Excellence in India, LTTS will enable customers and original equipment manufacturers (OEM) with a broader range of services and solutions to support their digital transformation journeys.”
Akshat Vaid, Partner at Everest Group said, “For some years now, innovation in mobility has been software and technology centric with themes such as hybrid and electric, autonomous driving, connected experiences, and shared mobility, continuing to be top ER&D spend segments. Cloud and edge computing are naturally at the front and centre in this new era of automotive engineering. Alliances between cloud leaders and engineering service providers will go a long way in helping OEMs in driving best engineering outcomes and in the process creating new possibilities for their end-consumers.”
About L&T Technology Services Ltd
L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 57 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 21,600 employees spread across 22 global design centers, 28 global sales offices and 91 innovation labs as of December 31, 2022. For more information, please visit www.ltts.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005905/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 07:30:00 CEST | Press release
SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom